Global Radio pharmaceutical Information, by types (Diagnostic and Therapeutic Radio pharmaceuticals) by application (cardiology, thyroid, oncology, neurology, others) by end users (hospitals, research centers, clinics) – Forecast to 2022
The global dental diagnostic and surgical devices market is expecting a healthy growth at a CAGR of ~9.0% during forecast period (2017-2022).
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1650 .
KEY PLAYERS FOR RADIO PHARMACEUTICAL MARKET
Advanced Accelerator, Bracco Diagnostic Inc., Bayer, Canadian Nuclear Laboratories, Cardinal Health Inc., Eczacibasi-Monrol, Medtronic, General Electric Company, Siemens, Curium, Jubilant Life Sciences Ltd., Lantheus Medical Imaging, Inc., Nordion, Inc., NTP, Sun Pharmaceutical, Mallinckrodt Pharmaceuticals and others are some of the prominent players at the forefront of competition in the Global Radio Pharmaceutical Market and are profiled in MRFR Analysis.
MARKET SCENARIO FOR RADIO PHARMACEUTICAL MARKET
Radiopharmaceuticals are drugs which are utilized for therapeutic or diagnostic reasons. These pharmaceuticals are inclusive of radiosotope bond to an organic molecule. These organic molecules carry the radiosotope to tissues, specific organs and cells as the properties of radiosotope are specific. These radioisotopes emits penetrating gamma rays that are used for diagnostic imaging where the radiation has to escape the body before being detected by a specific device (SPECT/PET cameras).
Early diagnosis and treatment of chronic diseases outlines the importance of advanced imaging technologies and new radiopharmaceutical for diagnosis and treatment of diseases especially cancer. Healthcare providers are now using various radiopharmaceutical for cancer treatment by determining the demand and supply gap of healthcare resources. According to the World Cancer Research Fund International, in 2015, cancer was responsible for 8.8 million deaths, and is the second leading cause of death across the globe. Moreover, growing number of cardiovascular diseases has also upsurged the growth of the market. For instance, according to the American Heart Association, in 2017, about 92.1 million Americans were diagnosed with cardiovascular disease.
Get Discount @ https://www.marketresearchfuture.com/check-discount/1650 .
SEGMENTS FOR RADIO PHARMACEUTICAL MARKET
Global Radiopharmaceutical market has been segmented on the basis of types which comprises of the rapeutic and diagnostic radiopharmaceuticals, which majorly includes, PET, SPECT, and Beta emitter, among others. On the basis of end users the market is divided into; hospitals, clinics, research facilities and others. On the basis of application market is divided into; cardiology, thyroid, oncology, neurology and others.
REGIONAL ANALYSIS OF RADIO PHARMACEUTICAL MARKET
Globally North America is the largest market for radiopharmaceutical. The North American radiopharmaceutical market is growing at a significant pace because of increasing preference of targeted cancer therapy because of which the radiopharmaceuticals are growing in demand.
Request for TOC @ https://www.marketresearchfuture.com/request-toc/1650 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future, Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312